A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
about
Advances in the use of topical imiquimod to treat dermatologic disordersImiquimod for the treatment of genital warts: a quantitative systematic reviewTherapy of cutaneous human Papillomavirus infections.Human papillomavirus: clinical significance and malignant potential.Immunotherapy for nonmelanoma skin cancer: does it have a future?Imiquimod; an international update on therapeutic uses in dermatology.A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients.Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.Therapy of external anogenital warts and molluscum contagiosum: a literature review.Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod.Natural products and synthetic compounds as immunomodulators.Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection.Topical treatment of common warts in an HIV-positive patient with imiquimod 5% cream.Imiquimod: potential risk of an immunostimulant.Closing the feedback loop: an audit of the use of imiquimod for the treatment of genital warts.
P2860
Q24647413-1F225714-770E-4270-B363-7D9DF130EC4CQ24799636-0298C061-D78E-4FF5-BBE1-4CD0D421BA8CQ31133083-3F5313E5-DADF-477F-9248-4728EEB926B7Q34394146-3DFDE045-2B28-48C1-BEB1-228AFDF11E18Q34568136-E151A9EE-CBE7-4A5D-A498-3159AA0D5E54Q35009563-4532CB91-4232-444D-930D-52DB56802219Q35199570-10770284-E23E-4CD9-875E-6915A4576BA5Q35583151-F27F01CA-1713-4FB7-B45E-48FF5415B45AQ35646050-17C6C928-3260-48B1-B72A-6AF87BD6CB0AQ35697191-9FA7FA2B-3443-4F6D-8499-F62BEEAF2D5DQ35917221-7B2F9D86-9BCA-4688-898B-443974B362F6Q36373370-537E8A0A-E9BC-434A-934E-296BAD6CADA1Q43885196-D2A92186-C9FE-4330-ABBE-F188CFF6DA2DQ44655289-6602AD85-63C3-4CC9-91B5-E8808B34D2C2Q44833308-73E321F8-6C28-4ABD-BBA2-AD24D26A2C40Q44850847-02C2CF90-0199-4C7A-A750-4CD3C110E001
P2860
A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A randomized, controlled, safe ...... tients. Imiquimod Study Group.
@en
A randomized, controlled, safe ...... tients. Imiquimod Study Group.
@nl
type
label
A randomized, controlled, safe ...... tients. Imiquimod Study Group.
@en
A randomized, controlled, safe ...... tients. Imiquimod Study Group.
@nl
prefLabel
A randomized, controlled, safe ...... tients. Imiquimod Study Group.
@en
A randomized, controlled, safe ...... tients. Imiquimod Study Group.
@nl
P2093
P1433
P1476
A randomized, controlled, safe ...... tients. Imiquimod Study Group.
@en
P2093
A E Friedman-Kien
A T Nayagam
D C Pietig
J L Shupack
M A Conant
R J Gilson
P304
P356
10.1097/00002030-199912030-00011
P407
P577
1999-12-01T00:00:00Z